Perkin, Journal of the Chemical Society, 1902, vol. 81, p. 1059
作者:Perkin
DOI:——
日期:——
v. Kostanecki; Rost, Chemische Berichte, 1903, vol. 36, p. 2205
作者:v. Kostanecki、Rost
DOI:——
日期:——
COMPOUNDS TARGETING MUTANT CALRETICULIN
申请人:MYELOPRO DIAGNOSTICS AND RESEARCH GmbH
公开号:US20220024944A1
公开(公告)日:2022-01-27
The present invention relates to compounds binding to calreticulin which selectively inhibit growth of CALR mutant cells and/or exhibit selective cytotoxicity towards CALR mutant cells, to pharmaceutical compositions comprising such compounds as well as to their use in treating diseases or conditions caused by or associated with a mutation of CALR, in particular myeloid malignancies, such as myeloproliferative neoplasms or myelodysplasia syndrome. The present invention also relates to screening assays allowing the identification of such compounds.